In support of scientific research, society places value on two potentially inconsistent objectives: promoting objectivity in the scientific process while simultaneously promoting commercialization of the results of that process. These potentially inconsistent objectives at the institutional level will be explored in an interactive discussion between individuals representing academic medical centers and participants from research and government agencies.
On January 27, 2011, a panel of experts held an academic discussion around a set of 
hypothetical scenarios regarding the issues that emerge when academic medical centers engage in medical research.
A summary of the academic collaborative discussion is presented here in this White Paper. Please contact Katherine Wone at (202) 833-0787 or at kwone@healthlawyers.org if you have any questions.
Our speakers for the January 27 Convener Session included:
Dawn R. Crumel
Senior Associate Counsel/Director, Children's National Medical Center
Washington, DC
Dr. Harvey V. Fineberg
President, Institute of Medicine of the National Academies
Washington, DC
Dr. Stuart Horowitz
Managing Director, Huron Consulting Group
Chicago, IL
Ann N. James
Senior University Counsel, Stanford University
Stanford, CA
Melissa Markey
Shareholder, Hall Render Killian Heath & Lyman PC
Troy, MI
Lewis Morris
Chief Counsel to the Inspector General, DHHS Office of Inspector General
Washington, DC
Sally J. Rockey, PhD
Deputy Director, Extramural Research, National Institutes of Health
Bethesda, MD
Jeff Sconyers
Senior Vice President & General Counsel, Children's Hospital & Regional Medical Center
Seattle, WA
Lisa Vandecaveye
Corporate Vice President of Legal Affairs, Botsford Health Care Continuum
Farmington Hills, MI